BRWA
VIVO

B. Riley Wealth Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

B. Riley Wealth Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-200
Closed -$4.13K – 2019
2014
Q2 		$4.13K Buy
+200
New +$4.11K ﹤0.01% 2096

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

B. Riley Wealth Advisors's VIVO Position: Q3 2014 in Review

B. Riley Wealth Advisors sold out of Meridian Bioscience Inc (VIVO) in Q3 2014, closing a stake of 200 shares — an estimated $4.13K sold.

B. Riley Wealth Advisors first reported a position in VIVO in Q2 2014 and held it in 1 quarter. The position peaked at $4.13K in Q2 2014. 161 funds tracked by Wall St. Rank hold VIVO as of Q3 2014.

  • B. Riley Wealth Advisors reported no remaining Meridian Bioscience Inc position as of Q3 2014 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 200 Meridian Bioscience Inc shares in Q3 2014, an estimated $4.13K.
  • B. Riley Wealth Advisors first reported a position in Meridian Bioscience Inc in Q2 2014 and held it in 1 quarter.
  • B. Riley Wealth Advisors's Meridian Bioscience Inc position peaked at $4.13K in Q2 2014.
  • 161 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2014.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.